274 related articles for article (PubMed ID: 10211085)
1. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
[TBL] [Abstract][Full Text] [Related]
2. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
Litière S; Werutsky G; Fentiman IS; Rutgers E; Christiaens MR; Van Limbergen E; Baaijens MH; Bogaerts J; Bartelink H
Lancet Oncol; 2012 Apr; 13(4):412-9. PubMed ID: 22373563
[TBL] [Abstract][Full Text] [Related]
3. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
Kontos M; Allen DS; Agbaje OF; Hamed H; Fentiman IS
Eur J Surg Oncol; 2011 Dec; 37(12):1051-8. PubMed ID: 21843919
[TBL] [Abstract][Full Text] [Related]
5. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
6. Breast-conserving therapy: a viable option for young women with early breast cancer--evidence from a prospective study.
Xie Z; Wang X; Lin H; Wei W; Liu P; Xiao X; Xie X; Guan X; Yang M; Tang J
Ann Surg Oncol; 2014 Jul; 21(7):2188-96. PubMed ID: 24599412
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Tong D; Winter J
Eur J Cancer; 1992; 28A(4-5):801-5. PubMed ID: 1524898
[TBL] [Abstract][Full Text] [Related]
8. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
Elkhuizen PH; van Slooten HJ; Clahsen PC; Hermans J; van de Velde CJ; van den Broek LC; van de Vijver MJ
J Clin Oncol; 2000 Mar; 18(5):1075-83. PubMed ID: 10694560
[TBL] [Abstract][Full Text] [Related]
9. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
[TBL] [Abstract][Full Text] [Related]
10. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer.
Noguchi M; Yagasaki R; Kawahara F; Minami M; Tsuyama H; Earashi M; Kinoshita K; Taniya T; Miwa K; Nishijima H; Takanaka T; Kawashima H; Takashima C; Kanno M; Nakamura S; Mizukami Y; Nonomura A; Michigishi T; Yokoyama K
Int Surg; 1997; 82(3):289-94. PubMed ID: 9372377
[TBL] [Abstract][Full Text] [Related]
11. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
[TBL] [Abstract][Full Text] [Related]
12. Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort.
Lyngholm CD; Laurberg T; Alsner J; Damsgaard TE; Overgaard J; Christiansen PM
Acta Oncol; 2016 Aug; 55(8):983-92. PubMed ID: 27120011
[TBL] [Abstract][Full Text] [Related]
13. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.
Fentiman IS; Christiaens MR; Paridaens R; Van Geel A; Rutgers E; Berner J; de Keizer G; Wildiers J; Nagadowska M; Legrand C; Therasse P;
Eur J Cancer; 2003 Feb; 39(3):309-16. PubMed ID: 12565982
[TBL] [Abstract][Full Text] [Related]
14. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).
Curran D; van Dongen JP; Aaronson NK; Kiebert G; Fentiman IS; Mignolet F; Bartelink H
Eur J Cancer; 1998 Feb; 34(3):307-14. PubMed ID: 9640214
[TBL] [Abstract][Full Text] [Related]
15. Breast conservative therapy in east part of China: a retrospective cohort study.
Fan J; Wang L; Wang XJ; Wu J; Lu JS; Di GH; Shen KW; Han QX; Liu BL; Shen ZZ; Shao ZM
J Cancer Res Clin Oncol; 2006 Sep; 132(9):573-8. PubMed ID: 16741727
[TBL] [Abstract][Full Text] [Related]
16. Local-regional control in breast cancer patients with a possible genetic predisposition.
Freedman LM; Buchholz TA; Thames HD; Strom EA; McNeese MD; Hortobagyi GN; Singletary SE; Heaton KM; Hunt KK
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):951-7. PubMed ID: 11072150
[TBL] [Abstract][Full Text] [Related]
17. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
Laurberg T; Lyngholm CD; Christiansen P; Alsner J; Overgaard J
Radiother Oncol; 2016 Jul; 120(1):98-106. PubMed ID: 27289261
[TBL] [Abstract][Full Text] [Related]
18. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
Acta Oncol; 2018 Jan; 57(1):3-12. PubMed ID: 29205077
[TBL] [Abstract][Full Text] [Related]
19. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen.
Fentiman IS; van Zijl J; Karydas I; Chaudary MA; Margreiter R; Legrand C; Therasse P;
Eur J Cancer; 2003 Feb; 39(3):300-8. PubMed ID: 12565981
[TBL] [Abstract][Full Text] [Related]
20. Is mastectomy superior to breast-conserving treatment for young women?
Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
